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Background: Patellar tendinopathy is a common cause of activity-related anterior knee pain. Evidence is conflicting as
to whether obesity is a risk factor for this condition. The aim of this study was to determine the relationship between
obesity and prevalence of magnetic resonance imaging (MRI) defined patellar tendinopathy in community-based
adults.
Methods: 297 participants aged 50–79 years with no history of knee pain or injury were recruited from an existing
community-based cohort. Measures of obesity included measured weight and body mass index (BMI), self-reported
weight at age of 18–21 years and heaviest lifetime weight. Fat-free mass and fat mass were measured using bioelectrical
impedance. Participants underwent MRI of the dominant knee. Patellar tendinopathy was defined on both T1- and
T2-weighted images.
Results: The prevalence of MRI defined patellar tendinopathy was 28.3%. Current weight (OR per kg = 1.04, 95%
CI 1.01-1.06, P = 0.002), BMI (OR per kg/m2 = 1.10, 95% CI 1.04-1.17, P = 0.002), heaviest lifetime weight (OR per kg = 1.03,
95% CI 1.01-1.05, P = 0.007) and weight at age of 18–21 years (OR per kg = 1.03, 95% CI 1.00-1.07, P = 0.05) were all
positively associated with the prevalence of patellar tendinopathy. Neither fat mass nor fat-free mass was associated
with patellar tendinopathy.
Conclusion: MRI defined patellar tendinopathy is common in community-based adults and is associated with current
and past history of obesity assessed by BMI or body weight, but not fat mass. The findings suggest a mechanical
pathogenesis of patellar tendinopathy and patellar tendinopathy may be one mechanism for obesity related anterior
knee pain.
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Patellar tendinopathy is a clinical condition causing
activity-related anterior knee pain and subsequent
dysfunction [1,2]. It has been most commonly described
in athletes participating in sports that involve jumping,
earning it the name “jumper’s knee”, where the tendon
matrix is affected by repetitive stress on the tendon* Correspondence: yuanyuan.wang@monash.edu
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unless otherwise stated.[3,4], but patellar tendinopathy has also been found in
people who do not participate in jumping sports [3,5].
The prime pathological feature of patellar tendinopathy
histologically is characterised by mucoid degeneration
which can be detected using ultrasonography or magnetic
resonance imaging (MRI) [6-8]. Although not all individuals
with evidence of patellar tendinopathy on imaging have
symptoms [6,9], those tendon abnormalities identified by
imaging modality in asymptomatic individuals predict the
development of tendon-related symptoms and disability
[10,11]. In addition, these imaging changes are not alwaysLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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This may in part be due to the incorrect attribution of
symptoms to patellar tendinopathy when other joint
pathology may be the source of symptoms [12,13].
MRI has advanced our understanding of factors that
contribute to pain and function in the tibiofemoral
joint [14,15]. These structural changes in and around the
knee joint develop on a continuum from the healthy joint
to the diseased joint.
Pathology in the patellofemoral compartment is increas-
ingly recognised as a source of pain and impaired function
with aging [16,17]. However, there has been relatively little
work at the patellofemoral joint, compared with the
tibiofemoral joint, examining structures such as tendons.
Most of the instruments examining pain and function in
epidemiological and clinical studies of older people focus
on the tibiofemoral compartment and do not address
symptoms that may be due to patellar tendinopathy, such
as activity-related anterior knee pain through important
functional activities such as knee bending.
A large body of work on patellar tendinopathy performed
using athletic populations has identified male gender
[18-20] and body mass [3,21,22] as risk factors. The evi-
dence is conflicting about any association between patellar
tendinopathy and obesity, a condition which is known
to increase strain on joints and tendons throughout
the body, especially the weight-bearing joints, with
some studies showing no association [18,23]. Any associ-
ation between body composition and risk of patellar tendi-
nopathy is also inconclusive [21,23]. In older populations,
obesity has been related to knee pain and poor function
[24,25]. It is possible that patellar tendon pathology may
be one of the mechanisms for obesity related anterior
knee pain in older people.
Thus the aim of the current study was to determine
the prevalence of MRI defined patellar tendinopathy in
community-based asymptomatic adults and whether it is
associated with obesity and body composition. Examining
this in an asymptomatic population may reduce the
potential for any associations identified being due to
reverse causation. We hypothesised that obesity would
be associated with increased risk of MRI defined patellar
tendinopathy in community-based individuals.
Methods
Study participants
The study was conducted within the Melbourne
Collaborative Cohort Study (MCCS), a prospective cohort
study of 41,514 residents of Melbourne, Australia. The
aim of the MCCS is to examine the role of lifestyle and
genetic factors in the risk of cancer and chronic diseases
[26]. Participants for the current study were recruited
from within the MCCS between 2003–2004 as described
[27]. Briefly, participants were eligible if they wereaged between 50–79 years without any of the following
exclusion criteria: a clinical diagnosis of knee osteoarthritis
as defined by American College of Rheumatology criteria
[28]; knee pain lasting for > 24 hours in the last 5 years; a
previous knee injury requiring non-weight bearing
treatment for > 24 hours or surgery (including arthroscopy);
or a history of any form of arthritis diagnosed by a medical
practitioner. A further exclusion criterion was a contraindi-
cation to MRI including pacemaker, metal sutures, presence
of shrapnel or iron filings in the eye, or claustrophobia.
The study was approved by The Cancer Council Victoria’s
Human Research Ethics Committee and Monash University
Human Research Ethics Committee. All participants gave
written informed consent.
Anthropometric measurements
At baseline (2003–2004), height (cm) was measured using a
stadiometer with shoes removed, and weight (kg) was
measured with bulky clothing removed. Body mass index
(BMI) was calculated from these data [weight (kg)/height2
(m2)]. Bioelectrical impedance analysis was performed with
a single frequency (50 kHz) electric current produced
by a BIA-101A RJL system analyser (RJL systems, Detroit,
MI). Resistance and reactance were measured with partici-
pants in a supine position. Non-adipose mass, hereafter
termed fat-free mass, was estimated as 9.1536 + (0.4273 ×
height2/resistance) + (0.1926 ×weight) + (0.0667 × reactance)
for males, and 7.7435 + (0.4542 × height2/resistance) +
(0.119 × weight) + (0.0455 × reactance) for females [29].
Adipose mass, hereafter termed fat mass, was subsequently
calculated as weight – fat-free mass. There is evidence for
the validity and reliability of bioelectrical impedance ana-
lysis in determining body composition [30,31]. A particular
issue for bioelectric impedance analysis is the absence of a
standard equation to estimate fat-free mass. We chose a
formula developed using subjects of similar ethnicity, age,
and BMI distribution to the MCCS population [29] and
validated using sound statistical techniques. At MCCS
baseline (1990–1994), participants were also asked to re-
call their weight when they were aged between 18–21
years and their heaviest lifetime weight.
MRI acquisition
An MRI of the dominant knee (defined as the lower-limb
from which the participant stepped off from when initi-
ating gait) was performed between October 2003 and
December 2004 and repeated approximately 2 years
later. Knees were imaged in the sagittal plane on a 1.5-T
whole body magnetic resonance unit (Gyroscan Intera,
Philips Medical Systems, Eindhoven, The Netherlands)
using a commercial transmit-receive extremity coil. The
following sequence and parameters were used: a T1-
weighted fat suppressed 3D gradient recall acquisition
in the steady state; flip angle 55 degrees; repetition time
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titions; 512 × 512 matrix; one acquisition time 11 min
56 sec. Sagittal images were obtained at a partition
thickness of 1.5 mm and an in-plane resolution of
0.31 × 0.31 mm (512 × 512 pixels). In addition, a coronal
T2-weighted fat-saturated acquisition, repetition time
3500–3800 msec, echo time 50 msec, with a slice thick-
ness of 3.0 mm, a 1.0 mm interslice gap, 1 excitation, a
field of view of 13 cm, and a matrix of 256 × 192 pixels
was also obtained.
Assessment of patellar tendinopathy
Patellar tendinopathy was defined as an area of increased
signal intensity of characteristic pattern, size and distribu-
tion on at least two adjacent slices in the proximal region
of the inferior patellar tendon. Two trained observers,
who were blinded to participant characteristics, assessed
the presence of lesions for each participant in T1-weighted
fat-saturated sagittal images. T2-weighted fat-saturated
coronal images were used to confirm the presence of
patellar tendinopathy and ensure a magic angle effect was
not contributing to positive results. When echo time is
short, increased signal intensity can be observed in the
absence of pathology, which is known as the magic angle
effect. To overcome the magic angle effect a T2-weighted
sequence can be applied [32], which was done in this
study. The patellar tendon was graded as either ‘definite
tendinopathy’ or ‘no tendinopathy’ [9,32,33] (Figure 1).
The reproducibility for determination of definite patellar
tendinopathy was assessed using 50 randomly selected
knee MRIs (intraclass coefficient correlation was 0.94).
Statistical analysis
The outcome measure was the prevalence of MRI defined
patellar tendinopathy. The exposures of interest were
different body mass measurements (weight, BMI, and
body composition). Binary logistic regression was used to
examine the association between body mass measures andA
Figure 1 Patellar tendinopathy on MRI on A. T1-weighted fat-saturatedthe prevalence of MRI defined patellar tendinopathy,
adjusting for confounders of age, gender, and height (for
body weight only). A p-value of less than 0.05 (two-tailed)
was regarded as statistically significant. All analyses were
performed using IBM SPSS version 20.
Results
The characteristics of the 297 participants aged between
50 and 79 years (mean 58.0 years, SD 5.5 years) are pre-
sented in Table 1. Participants with patellar tendinopathy
(n = 84, 28.3%) were more likely to be men (P < 0.001), tal-
ler (P = 0.02), and had greater body weight (P < 0.001) and
BMI (P = 0.001) than those without patellar tendinopathy.
Weight at the age of 18–21 years and heaviest lifetime
weight were also greater for those with tendinopathy com-
pared with those without (all P < 0.001). Two hundred and
thirty three (78.5%) participants had current fat mass and
fat free mass measures. Participants with patellar ten-
dinopathy had higher fat free mass than those without
(P < 0.001), but there was no significant difference in
fat mass between the two groups (P = 0.21).
Relationship between weight and BMI and prevalence of
patellar tendinopathy
In univariate analyses, BMI, body weight, weight at ages
of 18–21 years and heaviest lifetime weight were all
positively associated with the prevalence of patellar
tendinopathy (Table 2). After adjusting for age and
gender, BMI remained positively associated with the
prevalence of patellar tendinopathy (odds ratio (OR)
1.10, 95% confidence interval (CI) 1.04 - 1.17). Body
weight (OR 1.04, 95% CI 1.01 - 1.06) and heaviest lifetime
weight (OR 1.03, 95% CI 1.01 - 1.05) also remained
positively associated with the prevalence of patellar ten-
dinopathy after adjusting for age, gender and height.
Weight at ages of 18–21 years was marginally associated
with the prevalence of patellar tendinopathy (OR 1.03,
95% CI 1.00 - 1.07) (Table 2).B
sagittal MRI; and B. T2-weighted fat-saturated coronal MRI.






Age (years) 57.6 (5.2) 59.0 (6.0) 0.06
Female, number (%) 147 (69) 39 (46) <0.001
Height (cm) 167.3 (8.7) 170.0 (9.5) 0.02
Weight (kg) 71.3 (13.8) 78.9 (14.2) <0.001
Body mass index (kg/m2) 25.4 (4.2) 27.2 (4.2) 0.001
Fat-free mass (kg)† 44.4 (9.3) 51.7 (10.7) <0.001
Fat mass (kg)† 26.1 (9.0) 27.8 (8.4) 0.21
Weight at ages of 18–21
years (kg)
59.2 (11.1) 64.3 (11.3) <0.001
Heaviest lifetime
weight (kg)
71.1 (14.1) 78.7 (13.7) <0.001
Values are reported as mean (SD) except for percentages.
*Differences between those with and without patellar tendinopathy, using
independent samples t test or Chi-squared test.
†Data available on 233 participants.
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of patellar tendinopathy
In univariate analyses, fat free mass was positively associ-
ated with the prevalence of patellar tendinopathy but there
was no significant association with fat mass (Table 3). After
adjusting for age and gender, the significant association
with fat free mass remained (OR 1.08, 95% CI 1.01 - 1.15)
while fat mass was weakly associated with the prevalence of
patellar tendinopathy (OR 1.03, 95% CI 1.00 - 1.07). After
adjustment for fat free mass and fat mass along with
age and gender, neither fat free mass (OR 1.07, 95% CI
0.99 - 1.16) nor fat mass (OR 1.01, 95% CI 0.96 - 1.05)
were significantly associated with the prevalence of
patellar tendinopathy (Table 3).
Discussion
In community-based adults without clinical knee disease,
MRI defined patellar tendinopathy was common (28.3%).
There was an increased risk of MRI defined patellar tendi-
nopathy associated with both current and past history of
obesity as assessed by either BMI or body weight. Neither
fat mass nor fat free mass was associated with the risk
of MRI defined patellar tendinopathy when they were
co-adjusted.Table 2 Associations of weight and body mass index with pre
Univariate ana
Odds ratio (95% CI)
Body mass index (kg/m2)1 1.10 (1.04, 1.17)
Weight (kg)2 1.04 (1.02, 1.06)
Weight at ages of 18–21 years (kg)2 1.04 (1.02, 1.07)
Heaviest lifetime weight (kg)2 1.04 (1.02, 1.06)
1adjusting for age and gender.
2adjusting for age, gender, and height.Existing studies aimed at determining the prevalence
of patellar tendinopathy have used young athletic popu-
lations, both elite and non-elite. Patellar tendinopathy,
which is also known as “jumper’s knee”, is traditionally
considered to be mainly a disease of athletes, especially
those participating in sports involving significant force
through the patellar tendon [2]. The prevalence and sig-
nificance of patellar tendinopathy have been illustrated
in a number of samples of athletes from different sports,
with prevalence ranging from 2.5% to 41% [3,20,34]. Data
are limited regarding the prevalence of patellar tendinopa-
thy in non-athletic, healthy middle-aged to older popula-
tions. Our study demonstrated that the prevalence of MRI
defined patellar tendinopathy was 28.3% in a community-
based population of adults without clinical knee disease,
supporting the findings from a previous study that
prevalence of patellar tendinopathy is increased in older
populations [35].
There is conflicting evidence for an association between
obesity and patellar tendinopathy. A clinical diagnosis of
patellar tendinopathy has been reported to be associated
with increased weight [3,21,22] and BMI [21,22] by a
number of studies of athletes, but there is also evidence
suggesting that weight is not a significant risk factor for
patellar tendinopathy [18,23]. Our study has demonstrated
a clear relationship between current and past history of
obesity and MRI defined patellar tendinopathy in an
asymptomatic older population. The value of examining a
population without clinical symptoms is important since
it is unlikely that the knee pain and function limitation
cause reduced mobility and increased obesity, i.e. the
potential reverse causality. It is more likely that obesity
contributes to these pathological tendon abnormalities.
Thus we highlight the unique contribution of our results
from an unselected middle-aged population in contribut-
ing to knowledge of patellar tendinopathy.
We found no relationship between body composition
(fat mass and fat free mass) and MRI defined patellar
tendinopathy when adjusting for age, gender, fat mass
and fat free mass. This is supported by the findings from
a previous study that there is no clear link between body
composition and patellar tendinopathy in elite female
basketball players [23]. On the other hand, another studyvalence of patellar tendinopathy
lysis Multivariate analysis
P value Odds ratio (95% CI) P value
0.001 1.10 (1.04, 1.17) 0.002
<0.001 1.04 (1.01, 1.06) 0.002
0.001 1.03 (1.00, 1.07) 0.05
<0.001 1.03 (1.01, 1.05) 0.007
Table 3 Associations between body composition and prevalence of patellar tendinopathy
Univariate analysis Multivariate analysis1 Multivariate analysis2
Odds ratio (95% CI) P value Odds ratio (95% CI) P value Odds ratio (95% CI) P value
Fat free mass (kg) 1.07 (1.04, 1.10) <0.001 1.08 (1.01, 1.15) 0.02 1.07 (0.99, 1.16) 0.10
Fat mass (kg) 1.02 (0.99, 1.05) 0.21 1.03 (1.00, 1.07) 0.08 1.01 (0.96, 1.05) 0.78
1adjusting for age and gender.
2adjusting for age, gender, fat free mass and fat mass.
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between central obesity assessed by waist circumference
and the risk of patellar tendinopathy [21]. The reasons
for the discrepancy of findings are not known, but may
be due to different study populations (different age group,
gender, and athletes vs. non-athletes) and different methods
used to assess body composition and patellar tendinopathy.
Further investigations are needed.
Our findings of a positive association between obesity
(past and present) and MRI defined patellar tendinopa-
thy and no association with body composition suggest a
mechanical effect of obesity on patellar tendinopathy.
This mechanism is supported by existing literature that
patellar tendinopathy is a disease of athletes who have
repeated heavy loading through the patellar tendon, espe-
cially sports involving jumping. Differences in prevalence
have been established for different sporting populations
[3,20,34]; the interpretation being that the degree of ten-
don strain varies between different sports. Previous studies
have shown a direct relationship between the number of
training sessions and physically demanding work and the
risk of patellar tendinopathy [23,36,37]. It is thus of inter-
est that increased mechanical load through the knee due
to obesity as assessed by either BMI or body weight is sig-
nificantly associated with the risk of patellar tendinopathy.
This is consistent with the histological basis for patellar
tendinopathy which shows matrix changes without any
inflammatory component [6,35].
The patellofemoral compartment is being increasingly
recognised as a major source of pain and disease [16,17].
Patellar tendinopathy can be debilitating and cause signifi-
cant morbidity [38]. Symptomatic patellar tendinopathy
may have a significant negative impact on activity, quality
of life and ultimately mental health [4,39]. Although a
standardised patellar tendon outcome measure has been
developed and extensively validated (Victorian Institute
of Sport Assessment, VISA) [40], most traditional and
validated instruments for assessing knee pain (such as the
Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC) scoring system [41]) focus on the tibio-
femoral compartment rather than the patellofemoral com-
partment. It is well recognized that functional limitations
in activities such as knee bending, which have significant
impact on knee function, are common in older people.
Pathology in the patellofemoral compartment has a
significant impact on pain and quality of life [16,17].Whether symptoms in the region are due to joint path-
ology or other structures such as patellar tendinopathy
has not been examined. Our study suggests that MRI de-
fined patellar tendinopathy is common in older people.
Using a non-specific tool (WOMAC), we found some
trends for worse knee functions in older people with MRI
defined patellar tendinopathy compared with those with-
out (data not shown). However, further work using spe-
cific tools will be needed to determine whether patellar
tendinopathy explains some of the anterior knee pain and
common functional abnormalities seen in older people
but not explored by commonly used knee instruments.
This study has limitations. Although the cross-sectional
design enabled us to generate hypotheses and add to
current evidence using a reasonably sized population, the
findings of this cross-sectional study need to be confirmed
by longitudinal studies. Further investigation will be re-
quired to detail the natural history and other contributing
factors for patellar tendinopathy, particularly clarifying
whether the disease process has been there since early
adulthood or whether it has developed later in life. The
participants were asked to recall their weight at 18–21
years at the MCCS inception (1990–1994) when they were
aged 40–69 years. Self-report of past weight over a similar
period to our study has shown moderate to strong correl-
ation with measured weight (correlation coefficients range
from 0.64 to 0.95), and these correlations are modified by
sex and current weight [42-44]. Moreover, the reliability of
self-reported past weight is generally supported in epide-
miologic studies [42-44]. The main strength of the study
is that patellar tendinopathy has been measured using a
non-invasive MRI-based method from both T1- and
T2-weighted images to encounter the magic angle
effect which showed high reproducibility. In this study
we recruited participants with no history of knee dis-
ease from a community-based cohort. However we did
not specifically ask about knee pain on bending, which
would be more specific for patellar tendinopathy. Given
the participants did not have significant knee pain, it is
unlikely that knee pain restricted activity sufficiently to
contribute to the obesity.
Conclusions
Our study highlights a significant prevalence of MRI
defined patellar tendinopathy of 28.3% in a sample of
community-based adults. The positive association of
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http://www.biomedcentral.com/1471-2474/15/266MRI defined patellar tendinopathy with both current
and past obesity, but not body composition, suggests a
mechanical mechanism. The contribution of MRI defined
patellar tendinopathy on knee symptoms associated with
obesity in the older people warrants further investigation.
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